450 related articles for article (PubMed ID: 24723087)
1. Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options.
Maisch B; Ruppert V; Pankuweit S
Curr Heart Fail Rep; 2014 Jun; 11(2):166-77. PubMed ID: 24723087
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory dilated cardiomyopathy : Etiology and clinical management.
Maisch B; Pankuweit S
Herz; 2020 May; 45(3):221-229. PubMed ID: 32123933
[TBL] [Abstract][Full Text] [Related]
3. Management of acute fulminant myocarditis using circulatory support systems.
Reiss N; el-Banayosy A; Posival H; Morshuis M; Minami K; Körfer R
Artif Organs; 1996 Aug; 20(8):964-70. PubMed ID: 8853816
[TBL] [Abstract][Full Text] [Related]
4. Short-term use of "ECMELLA" in the context of fulminant eosinophilic myocarditis with cardiogenic shock.
Bohné M; Chung DU; Tigges E; van der Schalk H; Waddell D; Schenker N; Willems S; Klingel K; Kivelitz D; Bahlmann E
BMC Cardiovasc Disord; 2020 Dec; 20(1):519. PubMed ID: 33302874
[TBL] [Abstract][Full Text] [Related]
5. Management of Myocarditis-Related Cardiomyopathy in Adults.
Tschöpe C; Cooper LT; Torre-Amione G; Van Linthout S
Circ Res; 2019 May; 124(11):1568-1583. PubMed ID: 31120823
[TBL] [Abstract][Full Text] [Related]
6. Keeping immune checkpoint inhibitor myocarditis in check: advanced circulatory mechanical support as a bridge to recovery.
Stein-Merlob AF; Hsu JJ; Colton B; Berg CJ; Ferreira A; Price MM; Wainberg Z; Baas AS; Deng MC; Parikh RV; Yang EH
ESC Heart Fail; 2021 Oct; 8(5):4301-4306. PubMed ID: 34390221
[TBL] [Abstract][Full Text] [Related]
7. [Myocarditis].
Hékimian G; Combes A
Rev Med Interne; 2017 Aug; 38(8):531-538. PubMed ID: 28161113
[TBL] [Abstract][Full Text] [Related]
8. Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.
Maisch B; Alter P
Herz; 2018 Aug; 43(5):423-430. PubMed ID: 29947834
[TBL] [Abstract][Full Text] [Related]
9. Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options.
Maisch B
Front Cardiovasc Med; 2019; 6():48. PubMed ID: 31032264
[TBL] [Abstract][Full Text] [Related]
10. Acute myocarditis: an overview of pathogenesis, diagnosis and management.
Zafeiri M; Knott K; Lampejo T
Panminerva Med; 2024 Jun; 66(2):174-187. PubMed ID: 38536007
[TBL] [Abstract][Full Text] [Related]
11. [Update on myocarditis].
Moonen M; Lancellotti P
Rev Med Liege; 2018 May; 73(5-6):269-276. PubMed ID: 29926565
[TBL] [Abstract][Full Text] [Related]
12. ["Catecholamine refractory" cardiogenic shock? "Bridging-to-recovery" by implantation of a percutaneous cardiac assist device].
Wilde J; Klingel K; Kandolf R; Schuler G; Sandri M
Dtsch Med Wochenschr; 2013 Mar; 138(12):576-80. PubMed ID: 23483417
[TBL] [Abstract][Full Text] [Related]
13. [Successful management of a man with fulminant myocarditis using percutaneous cardiopulmonary support].
Ohkawa M; Nishikawa K; Takazawa T; Hinohara H; Kunimoto F; Goto F
Masui; 2005 Feb; 54(2):172-6. PubMed ID: 15747516
[TBL] [Abstract][Full Text] [Related]
14. Fulminant myocarditis.
Gupta S; Markham DW; Drazner MH; Mammen PP
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):693-706. PubMed ID: 18797433
[TBL] [Abstract][Full Text] [Related]
15. Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.
Maisch B; Pankuweit S
Herz; 2012 Sep; 37(6):644-56. PubMed ID: 22996288
[TBL] [Abstract][Full Text] [Related]
16. Assessment of myocardial recovery in a patient with acute myocarditis supported with a left ventricular assist device: a case report.
Maybaum S; Stockwell P; Naka Y; Catanese K; Flannery M; Fisher P; Oz M; Mancini D
J Heart Lung Transplant; 2003 Feb; 22(2):202-9. PubMed ID: 12581771
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, medical treatment, and stepwise mechanical circulatory support for fulminat myocarditis.
Saito S; Toda K; Miyagawa S; Yoshikawa Y; Hata H; Yoshioka D; Domae K; Tsukamoto Y; Sakata Y; Sawa Y
J Artif Organs; 2018 Jun; 21(2):172-179. PubMed ID: 29236180
[TBL] [Abstract][Full Text] [Related]
18. [Acute myocarditis].
Combes A
Rev Prat; 2013 May; 63(5):611-6. PubMed ID: 23789482
[TBL] [Abstract][Full Text] [Related]
19. Clinical determinants of successful weaning from extracorporeal membrane oxygenation in patients with fulminant myocarditis.
Matsumoto M; Asaumi Y; Nakamura Y; Nakatani T; Nagai T; Kanaya T; Kawakami S; Honda S; Kataoka Y; Nakajima S; Seguchi O; Yanase M; Nishimura K; Miyamoto Y; Kusano K; Anzai T; Noguchi T; Fujita T; Kobayashi J; Ishibashi-Ueda H; Shimokawa H; Yasuda S
ESC Heart Fail; 2018 Aug; 5(4):675-684. PubMed ID: 29757498
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for heart recovery in adult patients with acute fulminant myocarditis and cardiogenic shock supported with extracorporeal membrane oxygenation.
Chou HW; Wang CH; Lin LY; Chi NH; Chou NK; Yu HY; Chen YS
J Crit Care; 2020 Jun; 57():214-219. PubMed ID: 32220770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
